Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    "Afibrinogenemia"
Show Display Options
Rank Status Study
1 Withdrawn Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Conditions: Afibrinogenemia;   Hypofibrinogenemia;   Fibrinogen Deficiency
Interventions: Biological: Fibrinogen Concentrate, Human (FCH);   Biological: Cryoprecipitate
2 Not yet recruiting Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenaemia
Condition: Congenital Afibrinogenaemia
Intervention: Biological: Human Plasma-Derived Fibrinogen Concentrate
3 Recruiting Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency
Conditions: Hypofibrinogenemia, Congenital;   Afibrinogenemia, Congenital
Intervention: Drug: biological: human fibrinogen concentrate
4 Recruiting Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Conditions: Congenital Afibrinogenemia;   Congenital Hypofibrinogenemia
Intervention: Biological: BT524 (fibrinogen concentrate from human plasma)
5 Recruiting Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
Conditions: Congenital Fibrinogen Deficiency;   Afibrinogenemia
Interventions: Biological: Octafibrin  - (Factor I concentrate);   Biological: Haemocomplettan/Riastap (Factor I concentrate)
6 Completed
Has Results
Human Fibrinogen - Pharmacokinetics
Condition: Fibrinogen Deficiency
Intervention: Biological: Human Fibrinogen Concentrate
7 Recruiting Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery
Condition: Congenital Fibrinogen Deficiency
Intervention: Drug: Octafibrin
8 Recruiting Haemocomplettan® P During Elective Complex Cardiac Surgery
Condition: Fibrinogen Deficiency in Complex Cardiac Surgery
Interventions: Drug: Haemocomplettan® P;   Drug: Human albumin (Placebo)

Indicates status has not been verified in more than two years